Case Study 3 - Cardiovascular

Issue

Client had a product with an indication that could cover over 4 million UK patients and needed to focus this down to an acceptable level for NHS payors.

Solution

Initial research to identify the importance the NHS placed on each potential patient group.

A series of CAGs to explore the initial research findings in more depth

A second series of CAGs to test strategies and messages developed as a result of the initial CAGs

Output

A clear focus on a group of patients acceptable to the NHS in terms of numbers (i.e. cost) and clinical priority and an opportunity for meaningful market access discussions for the clients HDM team.